LEIDEN, Netherlands, Oct. 12,
2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming"
or "the Company") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR)
confirms it will announce financial results for the nine months
ended September 30, 2022 on
Thursday, October 27, 2022.
The Company will host a presentation for analysts at
13:30 CET/07:30 ET on October 27,
2022. Dial-in details for the presentation are detailed
below.
Conference call dial-in information
Thursday, October 27, 2022 13:30 CET/07:30
ET
Please note, the Company will only take questions from
dial-in attendees
Dial-in details:
Netherlands
(Local) +31
85 888 7233
United
Kingdom
+44 800 640 6441
United Kingdom (Local)
+44 20 3936 2999
United
States
+1 855 979 6654
United States
(Local) +1 646 664
1960
All other
locations
+44 20 3936 2999
Access code:
497472
Webcast
Link:
https://webcast.openbriefing.com/pharming-q32022/
About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is
a global biopharmaceutical company dedicated to transforming the
lives of patients with rare, debilitating, and life-threatening
diseases. Pharming is commercializing and developing an innovative
portfolio of protein replacement therapies and precision medicines,
including small molecules, biologics, and gene therapies that are
in early to late-stage development. Pharming is headquartered in
Leiden, Netherlands, and has
employees around the globe who serve patients in over 30 markets in
North America, Europe, the Middle
East, Africa, and
Asia-Pacific.
For more information, visit www.pharming.com or find us on
LinkedIn.
For further public information, contact:
Pharming
Group, Leiden, The
Netherlands
Heather Robertson, Investor Relations
& Corporate Communications Manager:
T: +31 71 5247 400
E: investor@pharming.com
FTI Consulting, London,
UK
Victoria Foster
Mitchell/Alex Shaw
T: +44 203 727 1000
FTI Consulting, USA
Jim Polson
T: +1 (312)
553-6730
LifeSpring Life Sciences Communication, Amsterdam, The Netherlands
Leon
Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl
Logo -
https://mma.prnewswire.com/media/1778344/Pharming_Group_NV_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/pharming-group-notice-of-q3-results-301646259.html